MMS22L and neoplasm: In conclusion, miR-8485-mediated downregulation of UBN2, ETS1, MMS22L, GSK3B, and SLC44A1 inhibits tumor progression through mechanisms involving cell cycle arrest, metastasis inhibition, apoptosis induction, and choline metabolism.